Lead aVR
ECG: Lead aVR
Lead avR can provide some unique insight into 5 different conditions:
- Acute MI
- Pericarditis
- Tricyclic antidepressants (TCA) and TCA-like overdose
- AVRT in narrow complex tachycardias
- Differentiating VT from SVT with aberrancy in wide complex tachycardias
Acute myocardial infarction
ST Elevation >1.5 mm in aVR
- Suggests left main coronary artery (LMCA), left anterior descending (LAD), or 3-vessel coronary disease
- LMCA occlusion has a high mortality and often refractory to thrombolytics.
- aVR ST elevation in ACS patients: Independent predictor of recurrent ischemic events in-hospital, heart failure, and death
Pericarditis
PR elevation in aVR
Suggests subepicardial atrial injury from pericardial inflammation
Multilead ST elevation:
- Differential diagnosis includes ACS vs pericarditis
- Concurrent PR elevation in aVR suggests pericarditis instead of ACS.
Tricyclic antidepressant (TCA) & TCA-like overdose
Prominent R wave in aVR
- Classic ECG findings of TCA overdose:
- Sinus tachycardia
- Widened QRS and QTc interval
- Right axis deviation 130-170 degrees
- Prominent terminal R wave in aVR
- Predictor of arrhythmia (Buckley et al. Crit Care, 2003):
- R/S ratio in aVR >0.7 (PPV 46%, NPV 95%)
AVRT in Wolff-Parkinson-White (WPW)
Atroventricular reentry tachycardia
- ST elevation in aVR in narrow complex tachycardia
- Narrow complex tachycardia ddx:
- AV node reentry tachycardia
- AV reentry tachycardia
- Atrial tachycardia
- ST elevation in aVR suggestive more of AVRT in WPW (sensitivity 71%, specificity 70%)
Vereckei criteria: VT versus SVT in wide complex tachycardia
Vereckei criteria:
- Asks 4 questions.
- More sensitive and specific to detect ventricular tachycardia (VT) than Brugada criteria.
Criteria looks ONLY at lead aVR (if answer is yes, then VT):
Is there an initial R wave?
- Is there a r or q wave >40 msec? (>1 small box width)
- Is there a notch on the descending limb of a negative QRS complex?
- Measure the voltage change in the first (vi) and last 40 msec (vt). Is vi / vt <1?
Criteria | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|
Brugada | 89% | 73% | 92% | 67% |
Verecki | 97% | 75% | 93% | 87% |
(Vereckei et al, Heart Rhythm 2008)
References
- Kireyev D et al.Clinical utility of aVR-The neglected electrocardiographic lead. Ann Noninvasive Electrocardiol. 2010;15(2):175-80. [PubMed]
- Riera AR et al.Clinical value of lead aVR. Ann Noninvasive Electrocardiol. 2011 Jul;16(3):295-302. [PubMed]
- Vereckei A, Duray G, Szénási G, Altemose GT, Miller JM. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008 Jan;5(1):89-98. doi: 10.1016/j.hrthm.2007.09.020. Epub 2007 Sep 20. [PubMed]
- Buckley NA et. al.The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.Crit Care. 2003 Oct;7(5):R101-7. Epub 2003 Aug 18. [PubMed]
- Williamson K et al. Electrocardiographic applications of lead aVR. Am J Emerg Med. 2006 Nov;24(7):864-74. [PubMed]